NASDAQ:IRTC iRhythm Technologies - IRTC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $115.05 +2.13 (+1.89%) (As of 03/20/2023 12:00 AM ET) Add Compare Share Share Today's Range$112.67▼$115.2450-Day Range$96.26▼$120.2552-Week Range$85.74▼$169.54Volume188,353 shsAverage Volume358,933 shsMarket Capitalization$3.48 billionP/E RatioN/ADividend YieldN/APrice Target$146.36 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media iRhythm Technologies MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside27.2% Upside$146.36 Price TargetShort InterestBearish7.05% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.20Based on 8 Articles This WeekInsider TradingSelling Shares$1.33 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.86) to ($2.19) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.32 out of 5 starsMedical Sector253rd out of 988 stocksSurgical & Medical Instruments Industry21st out of 101 stocks 4.4 Analyst's Opinion Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 8 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $146.36, iRhythm Technologies has a forecasted upside of 27.2% from its current price of $115.05.Amount of Analyst CoverageiRhythm Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.05% of the outstanding shares of iRhythm Technologies have been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 5.97%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRTC. Previous Next 2.9 News and Social Media Coverage News SentimentiRhythm Technologies has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for iRhythm Technologies this week, compared to 2 articles on an average week.Search Interest16 people have searched for IRTC on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.MarketBeat Follows3 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,331,058.00 in company stock.Percentage Held by InsidersOnly 1.64% of the stock of iRhythm Technologies is held by insiders.Percentage Held by Institutions98.96% of the stock of iRhythm Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($2.86) to ($2.19) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -29.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -29.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 14.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About iRhythm Technologies (NASDAQ:IRTC) StockiRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.Read More Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Stock News HeadlinesMarch 13, 2023 | marketbeat.com4 Stocks With Huge Cash Holdings at Silicon Valley Bank (IRTC)How the recent failure of Silicon Valley Bank leaves several companies with significant deposits stuck in the bank. Will regulators step in and save the day?March 17, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Lifted to "Hold" at StockNews.comMarch 20, 2023 | Weiss Ratings (Ad)Banking NightmareDuring and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …March 16, 2023 | markets.businessinsider.comMorgan Stanley Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)March 16, 2023 | americanbankingnews.comBrokerages Set iRhythm Technologies, Inc. (NASDAQ:IRTC) Target Price at $150.50March 16, 2023 | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMarch 12, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Stock Price Down 6.7%March 12, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Stock Price Down 6.7%March 20, 2023 | Investing Daily (Ad)How This Trader Banked A 97% Win RateDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. March 6, 2023 | finance.yahoo.comLarge Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG MonitorsMarch 2, 2023 | benzinga.comiRhythm Technologies Insider Trades Send a SignalMarch 2, 2023 | finance.yahoo.comFour New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCCFebruary 28, 2023 | msn.comiRhythm Technologies Earnings Perspective: Return On Capital EmployedFebruary 25, 2023 | seekingalpha.comiRhythm Technologies, Inc. (IRTC) Q4 2022 Earnings Call TranscriptFebruary 25, 2023 | finance.yahoo.comShould You Think About Buying iRhythm Technologies, Inc. (NASDAQ:IRTC) Now?February 24, 2023 | finance.yahoo.comiRhythm's Q4 Earnings Beat Expectations, Analysts Remain Bullish On Upcoming CatalystsFebruary 24, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (IRTC), Incyte (INCY) and Humana (HUM)February 24, 2023 | markets.businessinsider.comWhere iRhythm Technologies Stands With AnalystsFebruary 23, 2023 | finance.yahoo.comiRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial ResultsFebruary 23, 2023 | msn.comiRhythm Technologies Non-GAAP EPS of -$0.59 beats by $0.02, revenue of $112.62M beats by $2.34MFebruary 23, 2023 | finance.yahoo.comiRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial ResultsFebruary 22, 2023 | msn.comA Preview Of iRhythm Technologies's EarningsFebruary 21, 2023 | finance.yahoo.comWhat Makes iRhythm Technologies (IRTC) Stock an Attractive Investment?February 9, 2023 | finance.yahoo.comiRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023February 3, 2023 | seekingalpha.comiRhythm: Recent Snapback Rally Not Validated By Market Generated Data (Technical Analysis)January 30, 2023 | msn.comBest AI Stocks to Buy: Smart Artificial Intelligence InvestmentsJanuary 27, 2023 | forbes.comIRhythm TechnologiesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Company Calendar Last Earnings2/23/2023Today3/20/2023Next Earnings (Estimated)5/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IRTC CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees1,793Year FoundedN/APrice Target and Rating Average Stock Price Forecast$146.36 High Stock Price Forecast$190.00 Low Stock Price Forecast$105.00 Forecasted Upside/Downside+27.2%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($3.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-116,150,000.00 Net Margins-28.27% Pretax Margin-28.20% Return on Equity-35.85% Return on Assets-19.81% Debt Debt-to-Equity Ratio0.15 Current Ratio3.24 Quick Ratio3.07 Sales & Book Value Annual Sales$410.92 million Price / Sales8.46 Cash FlowN/A Price / Cash FlowN/A Book Value$7.96 per share Price / Book14.45Miscellaneous Outstanding Shares30,220,000Free Float29,720,000Market Cap$3.48 billion OptionableOptionable Beta1.41 Key ExecutivesQuentin S. BlackfordPresident, Chief Executive Officer & DirectorDouglas J. DevineChief Operating OfficerBrice BobzienChief Financial OfficerMark J. DayChief Technology OfficerMintu TurakhiaChief Medical & Scientific OfficerKey CompetitorsInari MedicalNASDAQ:NARIICU MedicalNASDAQ:ICUIHaemoneticsNYSE:HAEMerit Medical SystemsNASDAQ:MMSITandem Diabetes CareNASDAQ:TNDMView All CompetitorsInsiders & InstitutionsMark J DaySold 2,116 sharesTotal: $248,058.68 ($117.23/share)Patrick Michael MurphySold 571 sharesTotal: $66,938.33 ($117.23/share)Douglas DevineSold 1,473 sharesTotal: $172,679.79 ($117.23/share)Mark J DaySold 1,913 sharesTotal: $225,427.92 ($117.84/share)Douglas DevineSold 3,518 sharesTotal: $414,561.12 ($117.84/share)View All Insider TransactionsView All Institutional Transactions IRTC Stock - Frequently Asked Questions Should I buy or sell iRhythm Technologies stock right now? 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRTC shares. View IRTC analyst ratings or view top-rated stocks. What is iRhythm Technologies' stock price forecast for 2023? 10 Wall Street analysts have issued 1 year price objectives for iRhythm Technologies' shares. Their IRTC share price forecasts range from $105.00 to $190.00. On average, they expect the company's share price to reach $146.36 in the next year. This suggests a possible upside of 27.2% from the stock's current price. View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts. How have IRTC shares performed in 2023? iRhythm Technologies' stock was trading at $93.67 at the start of the year. Since then, IRTC shares have increased by 22.8% and is now trading at $115.05. View the best growth stocks for 2023 here. Are investors shorting iRhythm Technologies? iRhythm Technologies saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 2,130,000 shares, an increase of 6.0% from the February 13th total of 2,010,000 shares. Based on an average daily volume of 326,200 shares, the days-to-cover ratio is currently 6.5 days. View iRhythm Technologies' Short Interest. When is iRhythm Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023. View our IRTC earnings forecast. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) released its quarterly earnings data on Thursday, February, 23rd. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.63) by $0.04. The company had revenue of $112.62 million for the quarter, compared to analysts' expectations of $110.62 million. iRhythm Technologies had a negative net margin of 28.27% and a negative trailing twelve-month return on equity of 35.85%. What ETFs hold iRhythm Technologies' stock? ETFs with the largest weight of iRhythm Technologies (NASDAQ:IRTC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Robotics & Automation ETF (ROBO), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Principal Healthcare Innovators ETF (BTEC) and AI Powered Equity ETF (AIEQ). What guidance has iRhythm Technologies issued on next quarter's earnings? iRhythm Technologies issued an update on its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $475.00 million-$485.00 million, compared to the consensus revenue estimate of $485.60 million. What is Kevin M. King's approval rating as iRhythm Technologies' CEO? 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA). When did iRhythm Technologies IPO? (IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What is iRhythm Technologies' stock symbol? iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC." Who are iRhythm Technologies' major shareholders? iRhythm Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Sands Capital Management LLC (8.86%), Artisan Partners Limited Partnership (4.64%), LTS One Management LP (4.25%), Mackenzie Financial Corp (4.14%), Alliancebernstein L.P. (4.07%) and JPMorgan Chase & Co. (3.76%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy, Quentin S Blackford, Ralph Snyderman and Raymond W Scott. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iRhythm Technologies' stock price today? One share of IRTC stock can currently be purchased for approximately $115.05. How much money does iRhythm Technologies make? iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $3.48 billion and generates $410.92 million in revenue each year. The company earns $-116,150,000.00 in net income (profit) each year or ($3.89) on an earnings per share basis. How many employees does iRhythm Technologies have? The company employs 1,793 workers across the globe. How can I contact iRhythm Technologies? iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com. This page (NASDAQ:IRTC) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.